Value of ultrasound and contrast-enhanced ultrasound imaging in renal damage and treatment follow up of diabetic patients

Background: it aimed to explore the value of ultrasound and contrast-enhanced ultrasound (CEUS) in evaluating renal function damage and renal artery blood flow changes in patients with diabetic nephropathy. Materials and Methods and Methods: 124 patients were rolled into an observation group receiving treatment with Shenkang injection (SKI) and a control group receiving conventional treatment. Various examination data from CEUS were compared between the two groups. Results: observation group showed notable improvements relative to control group in renal function indicators, 24-hour urinary albumin levels, plasma viscosity, erythrocyte sedimentation rate, and fibrinogen levels. CEUS further confirmed that observation group had better outcomes in terms of renal volume and blood flow parameters relative to control group. Conclusion: these findings suggested that SKI treatment can effectively enhance renal function and renal artery blood flow in patients with diabetic nephropathy, making it an effective clinical treatment option.